Echocardiogram Study To Evaluate the Effect of the Novel Hepatitis C Virus NS5A Inhibitor GSK2336805 on Cardiac Contractility in Healthy Subjects

Lignende værker

• Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected with HCV Genotype 1
  af: Wilfret, D. A., et al.
  Udgivet: (2013)
• Preclinical Characterization of GSK2336805, a Novel Inhibitor of Hepatitis C Virus Replication That Selects for Resistance in NS5A
  af: Walker, Jill, et al.
  Udgivet: (2014)
• Effect of Rifampin on the Single-Dose Pharmacokinetics of Oral Cabotegravir in Healthy Subjects
  af: Ford, S. L., et al.
  Udgivet: (2017)
• Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects
  af: Adkison, Kimberly K., et al.
  Udgivet: (2005)
• Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects
  af: Lou, Yu, et al.
  Udgivet: (2016)